Skip to main content

Microneedling for Hair Growth: The Biology Explained

How does microneedling stimulate hair growth at the biological level?

Microneedling doesn't touch your hair at all. It works on the skin around the follicle, and the follicle reacts to whatever that skin does next, which is why the payoff shows up weeks after the redness has gone.

  • Platelet dump: Cut capillaries release growth factors into the dermis within seconds of each pass.
  • Cycle signal: Several of those molecules pull a resting follicle out of telogen early.
  • Wnt activation: Wounding switches on the pathway that governs hair shaft production.
  • Open channel: Punctures bypass the stratum corneum, so a topical reaches the follicle at higher dose.
The Bottom Line

Microneedling acts on hair indirectly, since punctures a few hundred microns deep trip the wound healing cascade, releasing platelet derived growth factor, vascular endothelial growth factor, epidermal growth factor and transforming growth factor beta, activating Wnt and beta-catenin signaling, and opening micro-channels that raise the dose a topical delivers to the follicle.

What happens in the skin during the first hours after a needle punctures the scalp?

Most of what matters here is finished before you've stopped looking pink. What separates a field of micro-punctures from a cut or a burn isn't chemistry, it's geometry: every channel is a narrow column ringed by intact tissue, so the skin closes it by migrating a few cell-widths rather than by building scar. You get the healing signal without paying the price a real wound charges.

  1. Hemostasis, within seconds: Platelets plug the breach and degranulate, releasing growth factors and a fibrin scaffold.
  2. Inflammation, minutes to hours: Neutrophils clear debris, then macrophages take over around the 24 to 48 hour mark.
  3. Proliferation, from about day two: Fibroblasts multiply, fresh collagen goes down, endothelial cells sprout new capillaries.
  4. Remodeling, over weeks: Disorganized type three collagen is quietly swapped for aligned type one.
Critical Insight

The endpoint used in the trial work is mild uniform erythema rather than pinpoint bleeding, because that colour shows the needles reached the papillary and upper reticular dermis where the capillary plexus sits, which is the depth that triggers the cascade without a meaningful scarring risk.

Which growth factors are released by controlled micro-injury and what does each one do to a follicle?

It's tempting to hunt for the one active ingredient in all this, and that's the mistake. What arrives is a package, and one member of it actively works against you, which is exactly why more injury isn't linearly better.

  • Platelet derived growth factor: Mitogenic for dermal papilla cells and tied to anagen induction and maintenance.
  • Vascular endothelial growth factor: Drives capillary sprouting; richer perifollicular supply means larger bulbs, thicker shafts.
  • Fibroblast growth factor family: FGF-7 pushes anagen while FGF-5 terminates it, so it isn't uniformly pro-growth.
  • Transforming growth factor beta: Closes the puncture, but also promotes catagen and drives fibrosis.
Key Fact

Measured growth factor elevation after needling is local and transient, generally days rather than weeks and far below the bolus delivered by a concentrated autologous plasma injection, so needling behaves as a repeated low amplitude stimulus that depends on cumulative sessions timed to the hair cycle.

How does Wnt and beta-catenin signaling connect needling to new hair shaft formation?

Wnt and beta-catenin is the switch that decides whether skin makes a hair at all. It patterns the placodes that become follicles before you're born, and in adult skin it runs the conversation between the dermal papilla and the epithelial stem cells that opens every new anagen. Injury is what plugs needling into it.

  1. Ligand rises: Wounding raises Wnt ligand expression in the healing epidermis and dermis.
  2. Destruction complex blocked: Ligand binding shuts down the complex that normally tags beta-catenin for degradation.
  3. Beta-catenin builds: It accumulates in the cytoplasm and translocates into the nucleus.
  4. Genes switch on: It partners with transcription factors to run the Lef1 program and the shaft keratins.
Worth Knowing

Wound induced follicle neogenesis is Wnt dependent, but it has been shown with full-thickness wounds far larger than a micro-puncture and robustly only in rodents, so the defensible claim for needling is that it nudges an existing, still-viable follicle toward anagen through the same signaling axis.

Where are hair follicle stem cells located and what wakes them up?

The reservoir sits higher up the follicle than most people expect, nowhere near the bulb everyone pictures. Two separate cell populations run the show, and keeping them straight is what explains why a stimulus applied at skin level has anything to act on at all.

Criteria Bulge Dermal papilla
Depth in a terminal follicle Roughly 1 to just under 2 mm At the bulb, around 4 mm
Cell type Slow-cycling epithelial stem cells, marked by keratin 15 and Lgr5 Mesenchymal cluster
Job Builds the shaft and the sheaths Instructs: sizes the hair, sets the cycle pace
Held in check by Bone morphogenetic protein and a fibroblast growth factor Releases the bulge once activating input crosses a threshold
Technical Verdict

Biopsy work repeatedly finds bulge stem cell numbers largely preserved in bald scalp while the progenitor population downstream is depleted, so androgenetic loss is a failure of activation rather than exhaustion, though once the follicular unit has been replaced by fibrous tract tissue there is no reservoir left to signal.

Why does increased blood vessel formation around a follicle matter for hair growth?

A hair in full anagen is one of the fastest proliferating structures in your body, with matrix keratinocytes dividing quicker than almost any other adult cell population. That metabolic bill has to be paid, and the perifollicular plexus is what pays it.

  • Supply line: Delivers oxygen, glucose and cysteine for keratin cross-linking, and carries waste away.
  • Cycle-linked: Vascular density expands entering anagen and regresses through catagen and telogen.
  • Size ceiling: Overexpressing vascular endothelial growth factor in animals thickens vessels and grows larger follicles.
Established Fact

Reduced perifollicular blood flow in balding scalp travels with miniaturization rather than clearly preceding it, so vascular supply is best read as a limit on how big a growing hair can get, not as the root cause of pattern hair loss.

How does needling push a resting follicle back into its growing phase?

Telogen isn't sleep, it's a held position. The follicle sits shortened with its club hair anchored and its stem cells inhibited, waiting for activating signals to outweigh the inhibitory tone of the niche, and injury is one of the oldest known ways to tip that balance. Micro-punctures are just a controlled, evenly distributed version of the same trick.

Earliest visible new growth: about 6 weeks, weekly sessions Measurable hair count difference: 12 weeks Shaft travel to the surface: about 4 mm Published session spacing: weekly to fortnightly
Expert Note

Trial evidence puts the earliest visible new growth at around six weeks of weekly sessions and a measurable difference in hair count at twelve weeks, while reviewers state plainly that the optimal frequency and interval have not been established.

What does needle depth actually reach in scalp tissue, and why does that determine the effect?

Depth is the single setting that separates biology from theatre. Adult scalp skin runs roughly one and three quarter to two millimetres in total with the epidermis taking only about a tenth of that, so almost everything you're aiming at sits in dermis, and each structure lives at its own address. Treat the number on the dial as a claim, not a fact, because skin deflects before it punctures and effective depth always runs shorter than nominal.

Epidermis, about 0.1 mm: Opens transient channels that help a topical get in, and little else.
No vessel disruption means no meaningful platelet or macrophage response
Upper dermis: Home of the superficial vascular plexus, which is where the injury cascade actually starts.
Bulge zone, roughly 1 to just under 2 mm: The stem cell reservoir, and the working ceiling for published protocols.
Studies have run from well under 1 mm up to about 2.5 mm with no gain from going deeper
Terminal follicle base, around 4 mm: Sits in subcutaneous fat, out of reach of any cosmetic device.
Compliance Note

A meta-analysis of the randomised trials found no significant difference in hair count between depths at or below one millimetre and depths above it, and a head-to-head comparison of 0.6 mm against 1.2 mm favoured the shallower setting, with reviewers stating that optimal device settings have not been established.

Does the mechanical stretch itself signal anything, separate from the wound response?

There's a second, quieter channel running alongside the wound cascade, and it's easy to oversell. Cells read physical force directly, and pushing a needle through dermis deforms the matrix well past the puncture itself. Where it gets shaky is the jump from that to hair.

  • Force sensors: Integrins, Piezo channels and YAP/TAZ read tension directly, no wound required.
  • Fast response: Stretched fibroblasts shift collagen and growth factor gene expression within minutes.
  • Thin evidence: No clean human scalp study separates a stretch effect from the injury alongside it.
Expert Insight

Mechanotransduction is the only plausible mechanism behind devices that puncture very shallowly without visible bleeding, and it's a weak one, because without breaching the capillary plexus there's no platelet release, no macrophage recruitment and no angiogenesis.

Why does creating channels in the scalp make topical hair loss treatments work better?

This half of the mechanism is physics, not biology. Your stratum corneum is a dense layer of dead corneocytes in a lipid matrix that blocks nearly everything above about five hundred daltons, which is why most of a topical applied to intact scalp never reaches the follicle in useful concentration. Needles turn that barrier into a perforated surface, and how long it stays perforated is something you control.

Site left uncovered: Impedance measurement in human subjects put the open window at under two hours.
Site kept occluded: The same channels stayed open anywhere from three to forty hours.
Straight after a session: Keep it to a clean scalp and hold off harsh products for a few days.
The Practical Move

The channel bypass is the most convincing explanation for the trial pattern in which needling plus a topical clearly outperforms the topical alone, and it's the same reason anything applied to a freshly needled scalp is going into the dermis, where alcohol or propylene glycol vehicles that only sting on intact skin can cause real irritation and non-sterile products carry an infection risk.

What happens biologically when needling is done too deep or too often?

Everything that makes this work has an inverted form on the far side of a threshold, and you don't want to find it by feel. The therapeutic window depends on each puncture staying small, isolated and fully resolved before the next one lands. Cross that line and the same controlled injury starts suppressing follicles instead of waking them.

  • Too deep or too wide: The wound outgrows simple migration closure, shifting regeneration toward fibrotic repair.
  • Too often: Re-injury before remodeling locks the dermis in chronic inflammation and transforming growth factor beta signaling.
  • Absolute exclusions: Active skin infection, keloid history, clotting disorders or anticoagulants, and scarring alopecia.
  • Warning signs: Redness outlasting a week, tenderness, crusting, or shedding that doesn't settle.
Authority Warning

The growth signal doesn't scale with injury, so an aggressive protocol is a one-way bet with no upside, since a follicle encased in fibrotic tissue loses the pliable matrix and the vascular access its cycle depends on, and that loss is permanent.

Daniel Zengel
Written by Daniel Zengel
Medical Writer
Daniel Zengel is the principal owner of H-SHOT and a medical writer covering platelet-rich plasma and hair restoration. He draws on more than a decade in pharmaceutical and medical device roles, with a focus on regenerative medicine and the device standards and provider training that make PRP results consistent from clinic to clinic.